Literature DB >> 21837428

Iatrogenic transtubal spill of endometrial cancer: risk or myth.

Onur Guralp1, David M Kushner.   

Abstract

INTRODUCTION: Although intrauterine procedures are essential for endometrial evaluation in many cases, the significance of the amount of tumor cell dissemination during these procedures, the viability and invasive potential of the endometrial cancer (EC) cells, and their impact on prognosis remain elusive.
MATERIALS AND METHODS: An extensive search was performed in the Cochrane Central Trials Registry, the Web of Science, and PubMed for publications about the role of hysteroscopy (H/S), saline infusion sonography (SIS) and laparoscopy (L/S) in dissemination of EC cells and prognostic significance of positive peritoneal washings (PPW), between 1988 and 2010 and English language. All eligible trials were included.
CONCLUSION: PPW rates vary between 0-14% after dilatation and curettage (D&C), 0-83% after H/S, 0-10% after L/S and 12-52% after SIS. The majority of the studies about EC cell dissemination during H/S and SIS suggest that they increase the risk of spill. There is not enough evidence to support the association between tumor spill and pressure, type and volume of distension medium, duration of the procedure, stage, grade and interval between H/S or SIS and laparotomy. Investigation into the rate of spill of EC cells during laparoscopic surgery is in the early stages and not yet definitive. There are too few in vivo and in vitro studies to comment definitively on the viability of the disseminated EC cells. The limited data we do have, however, questions the ability of disseminated EC cells to maintain and grow. Most published studies support the idea that prognosis is not affected by PPW in stage I EC. The changes in FIGO 2009 staging of EC appears to have merit when considering the sum of the data. H/S and SIS probably increase the risk of spill, however this increase does not seem effect prognosis. Although peritoneal washings are still expected to be performed, PPW itself does not necessitate additional treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21837428     DOI: 10.1007/s00404-011-2031-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  7 in total

1.  Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage.

Authors:  Andraz Dovnik; Bojana Crnobrnja; Branka Zegura; Iztok Takac; Maja Pakiz
Journal:  Radiol Oncol       Date:  2016-05-30       Impact factor: 2.991

2.  Intrauterine Fluid Instillation and Transtubal Flow: A Randomized Controlled In vitro Trial Comparing Gel and Water.

Authors:  Soetkin G Thijssen; Ruben R G Heremans; Meri Nderlita; Wouter J G Froyman; Susanne Housmans; Willy A J Poppe; Dirk Timmerman; Thierry Van den Bosch
Journal:  J Med Ultrasound       Date:  2019-09-06

Review 3.  Risk of tumor cell seeding through biopsy and aspiration cytology.

Authors:  K Shyamala; H C Girish; Sanjay Murgod
Journal:  J Int Soc Prev Community Dent       Date:  2014-01

4.  Vaginal implantation metastasis of endometrial carcinoma: A case report.

Authors:  Yueling Wang; Jiang DU; Shulan Lv; Yanxia Sui; Xue Xue; Chao Sun; Junkai Zou; Qunying Ma; Guoxing Fu; Qing Song; Qiling Li
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

5.  Risk of spilling cancer cells during total laparoscopic hysterectomy in low-risk endometrial cancer.

Authors:  Satoshi Shinohara; Ikuko Sakamoto; Masahiro Numata; Atsushi Ikegami; Katsuhiro Teramoto
Journal:  Gynecol Minim Invasive Ther       Date:  2016-12-31

6.  Risk Assessment of Endometrial Hyperplasia or Endometrial Cancer with Simplified Ultrasound-Based Scoring Systems.

Authors:  Norbert Stachowicz; Agata Smoleń; Michał Ciebiera; Tomasz Łoziński; Paweł Poziemski; Dariusz Borowski; Artur Czekierdowski
Journal:  Diagnostics (Basel)       Date:  2021-03-04

Review 7.  Role of uterine manipulator during laparoscopic endometrial cancer treatment.

Authors:  Vito Andrea Capozzi; Andrea Rosati; Stefano Uccella; Gaetano Riemma; Mattia Tarascio; Marco Torella; Pasquale De Franciscis; Nicola Colacurci; Stefano Cianci
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.